| BVEFX | RWMHX | BVEFX / RWMHX | |
| Total Expense Ratio | 0.78 | 0.41 | 190% |
| Annual Report Gross Expense Ratio | 1.04 | 0.41 | 254% |
| Fund Existence | 22 years | 10 years | - |
| Gain YTD | 3.472 | 2.599 | 134% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 101M | 208B | 0% |
| Annual Yield % from dividends | 1.24 | 1.38 | 89% |
| Returns for 1 year | 6.63 | 8.98 | 74% |
| Returns for 3 years | 13.32 | 31.87 | 42% |
| Returns for 5 years | 14.58 | 40.18 | 36% |
| Returns for 10 years | 62.75 | 102.06 | 61% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VTV | 198.41 | 0.73 | +0.37% |
| Vanguard Value ETF | |||
| DMAX | 26.68 | 0.01 | +0.03% |
| iShares Large Cap Max Buffer Dec ETF | |||
| AFIF | 9.44 | N/A | -0.02% |
| Anfield Universal Fixed Income ETF | |||
| KXI | 66.85 | -0.11 | -0.16% |
| iShares Global Consumer Staples ETF | |||
| BBC | 40.36 | -1.13 | -2.72% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||